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combined endpoint events the Group D, E increased signiﬁcantly. OR values were
1.451 and 1.902.
Conclusions: Admission white blood cell count was an independent risk factor for
short-term outcome in primary PCI with STEMI patients.
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Predictive factor of 30-day mortality in hospitalized patients with acute
myocardial infarction: A Cox-regression analysis in Beijing
Ke Xi1,2, Zongbin Li1, Jiayue Li1, Haili Lin1, Yusheng Zhao1
1Institute of Geriatric Cardiology, Chinese PLA General Hospital, 2Headquarters
clinic, Chinese People’s Armed Police general hospital
Objectives: Despite advances in the management of patients with acute myocardial
infarction, a variety of complications and death remain high during hospitalization of
acute myocardial infarction. Therefore, it is important that the risk factors of 30-day
mortality in patients with acute myocardial infarction are explored for improving the
outcomes of acute myocardial infarction.
Methods: All hospital admissions with a discharge diagnosis of acute myocardial
infarction were extracted from the Chinese PLA General Hospital Patients Infor-
mation System Database from the January 1st in 2011 to the December 31st 2012.
Cox’s regression on mortality was performed using SPSS19 statistical software for
the age, the sex, the history of diabetes, myocardial infarction, aerial ﬁbrillation,
stroke, chronic renal failure, anemia, or coronary artery bypass graft, the compli-
cation of cardiogenic shock, heart failure, ventricular ﬁbrillation/ventricular tachy-
cardia, atrioventricular block II, III degree, acute renal failure, gastrointestinal
hemorrhage, or multiple organ dysfunction syndrome and the percutenous coronary
intervention.
Results: Of 1869 cases, 91 (4.9%) patients (mean age 74.3  10.9 years old) died.
Among the patients, 1342 cases were male, and 437 cases female, mean age 61.1 
13.4 years old.. Univariate analysis showed age, sex, the history of diabetes,
myocardial infarction, aerial ﬁbrillation, stroke, chronic renal failure, anemia, or
coronary artery bypass graft, complication of cardiogenic shock, heart failure, ven-
tricular ﬁbrillation/ventricular tachycardia, atrioventricular block II, III degree, acute
renal failure, gastrointestinal hemorrhage, or multiple organ dysfunction syndrome
and percutenous coronary intervention were predictive factors of 30 day mortality.
Cox regression analysis indicated that the independent predictive factors of the 30 day
mortality rate were the age (odds ratio [OR] 1.065, 95% conﬁdence interval [CI]
1.042-1.089), the history of diabetes (OR 1.858, CI 1.190-2.901), or anemia (OR
2.893, CI 1.483-5.642), the complication of cardiogenic shock (OR 12.596, CI 7.454-
21.193), ventricular ﬁbrillation/ventricular tachycardia (OR 8.904, CI 4.000-19.821),
acute renal failure (OR 3.753, CI 1 814-7.765), or multiple organ dysfunction
syndrome (OR 4.060, CI 1.586-10.396), and the percutenous coronary intervention
(OR 0.345, CI 0.204-0.583).
Conclusions: The age, the history of diabetes, anemia, the complication of cardio-
genic shock, ventricular ﬁbrillation/ventricular tachycardia, acute renal failure, mul-
tiple organ dysfunction syndrome and the percutenous coronary intervention are
independent predictive factors of 30 days mortality in patients with acute myocardial
infarction.
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Objectives: The development of microvascular reperfusion injury is associated with
adverse clinical outcomes in patients with ST-elevation myocardial infarction
(STEMI) undergoing primary percutaneous coronary intervention (PCI). Upfront
strategies to reduce the incidence of microvascular reperfusion injury could be
considered for high-risk patients to improve outcomes. To examine the role of
intracoronary anisodamine and diltiazem administration performed before stenting on
the immediate angiographic and clinical outcomes.
Methods: STEMI patients with high-risk of no reﬂow presenting with primary PCI
were randomized to 2 bolus injections of intracoronary anisodamine (1mg/5mL)
and diltiazem (2mg/5mL) or diltiazem (2mg/5mL). The ﬁrst bolus injection was
given after guidewire and the second after the ﬁrst balloon inﬂation. The primary
endpoint was the incidence of no/slow reﬂow (TIMI ﬂow grade2) immediately
after stenting.
Results: A total of 108 patients were randomized to intracoronary anisodamine and
diltiazem (COM group, n¼54) or diltiazem (Diltiazem group, n¼54). The percents of
TIMI ﬂow grade 3 was found higher in the COM group than in the Diltiazem group
(92.6% vs 75.9%, p<0.05). TMPG 3 was obtained more frequently in the COM group
than in the Diltiazem group (68.5% vs 46.3%, p<0.05). cTFC was signiﬁcantly lower
in the COM group than in the Diltiazem group (30 vs 44, p<0.05). COM group had
showed low incidences of bradyarrhythmia and rapid arrhythmia (7.4% vs 24.1% and
3.7% vs 18.5%, respectively, p<0.05).
Conclusions: Intracoronary anisodamine and diltiazem administration before stenting
improved the angiographic results and prevented reperfusion arrhythmia in patients
with STEMI undergoing PCI.C130 JACC Vol 64/16/Suppl C j October 16–1GW25-e4324
MiRNA Expression and Identiﬁcation of CD4+T Lymphocytes in Patients with
Acute coronary syndrome
Gulao Zhang
the First Afﬁliated Hospital of Gannan medical university
Objectives: To screen differential microRNA expression proﬁles of CD4+T
lymphocyte from the patients with acute coronary sysdrome (ACS) and the healthy
controls by microarray analysis technique. To elucidate the mechanism responsible for
modulation of CD4+T lymphocyte and provide insights into the effects of microRNA
on ACS.
Methods: Ten patients with ACS were enrolled in the study, and ten patients with
normal coronary artery angiogram were served as a control group. Blood samples
were taken from peripheral vein and the CD4+T lymphocytes were isolated from
mononuclear cells prepared with Ficoll-Hypaque density-gradients centrifugation
from human peripheral blood by magnetic cell sorting system (MACS). The purity of
CD4+T lymphocytes was measured by ﬂow cytometry analysis. The viable count was
detected by the rejection experiment of trypanblau. Total RNA was abstracted from
CD4+T lymphocyte with Trizol reagent. McroiRNA was isolated and enriched of by
use of Polyethylene Glycol from 40mg total RNA.The microRNA extracted from
CD4+T lymphocytes was hybridized and microRNA expressions proﬁles of CD4+T
lymphocyte were screened with the Affymetrix GeneChip microRNA array. The
image signal was scanned by Affymetrix GeneChip Scanner 3000 and analysised by
Affymetrix GeneChip Command ConsoleTM 1.1 software. Then the image signal was
transformed into digital information, which was analysised with SAM software. The
differentially expressed microRNA were identiﬁed between the two groups. Real-time
quantitative polymerase chain reaction (qRT-PCR) was used to conﬁrm the result of
selected genes from microarray analysis.
Results: The results showed that the expression of mcroiRNA-155, microRNA-21,
microRNA-424 and microRNA-127-3p were over 1.5 folds up-regulated, and the
expression of microRNA-30b and microRNA-181a were over 0.5 folds down-regu-
lated in ACS group compared to the control group. The qRT-PCR results were in
accordance with those obtained using microarray analysis.
Conclusions: The differentially expressed microRNA of CD4+T lymphocyte may
participate in the the occuring and developing of ACS.
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The Relation of RDW with the Severity of Coronary Artery Disease and Long-
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Objectives: Red Blood Cell Distribution Width (RDW) is an indicator which can
react the degree of the dispersion of outer peripheral red blood cell volume. Recently,
studies have shown that the baseline of RDW is closely related with various heart
diseases. This study aimed to explore the changes of RDW in acute coronary syn-
drome (ACS), and to analyze the relation of RDW with the severity of coronary artery
disease and long-term (two-year ) prognosis.
Methods: A total of 218 patients (aged 27-85 years, 54.59% men) were enrolled in
this study, including 140 patients with ACS and 78 patients without ACS. The group
of ACS contained 60 patients with STEMI and 26 patients with NSTEMI and 54
patients with UA. All the patients had coronary arteriography (CAG), then Gensini
score was calculated. All detailed records of general condition and results of the
routine examinations were recorded. Every ACS patient had an interview by phone
after two years to evaluate adverse cardiovascular events during the two years, such as
angina pectorals grade of CCS raised at least of 1 grade, onset of heart failure,
recurrencerecurrence of myocardial infarction, cardiac death. According to the
thresholds of RDW determined by ROC curve analysis, ACS patients were divided
into high-levels group and low-levels group, the incidence of long-term adverse
cardiovascular events between the two groups was compared.
Results: (1) The average level of RDW was signiﬁcantly higher in ACS group than
it in control group [(12.810.55) % vs (12.280.41) %, P<0.001]. ACS patients
with myocardial infarction had higher level of RDW than those without myocardial
infarction [(12.920.57) % vs (12.630.46) %, P¼0.001].(2) Spearman correlation
analysis showed that RDW was positively associated with Gensini score signiﬁ-
cantly (r¼0.463, P<0.001), and also positive linear correlated with coronary artery
lesions (r¼0.295, P <0.001).(3) ROC curve analysis showed that test performance
was the best when RDW was 12.85%[area under curve¼0.87, P<0.01]. There were
57 cases of adverse cardiovascular events during the two-year follow-up periods.
Compared with low-levels group (RDW<12.85%), the incidence of long-term
cardiovascular events of high-levels group (RDW12.85%) increased signiﬁcantly
(56.72% vs 26.03%, P<0.001). Logistic regression analysis showed that NT-
proBNP (P¼0.007), LDL-C (P¼0.038), apolipoprotein-B (P¼0.030) and RDW
(P¼0.010) were the predictors of long-term adverse cardiovascular events.
(4) Spearman correlation analysis also showed that RDW was positively correlated
with WBC, AST, LDH, cTnI, hs-CRP, NT-proBNP and LVED, while it was
negatively relative with LVEF and MCV. Multiple stepwise regression analysis
showed that RDW was positively correlated with WBC (r¼0.232, P<0.001) and
hs-CRP (r¼0.352, P<0.001), while negatively correlated with LVEF (r¼-0.213,
P<0.001).
Conclusions: (1) The level of RDW in patients with ACS increased signiﬁcantly, and
ACS patients with AMI had higher level of RDW compared with those without AMI.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
(2) RDW was closely related with Gensini score. Patients with more severe coronary
artery disease had higher level of RDW. (3) RDW was relevant to the incidence of
long-term adverse cardiovascular events in ACS patients.RDW might be one of the
predictors for long-term adverse cardiovascular events in patients with ACS.(4)RDW
was signiﬁcantly correlated with WBC, hs-CRP, NT-proBNP and LVEF. High-levels
of RDW in ACS patients might be correlated with inﬂammatory reaction and
downgrade of cardiac function level.
GW25-e5136
Comparison of continuous platelet count method PL-11 with VASP for
monitoring the platelet aggregation function
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Objectives: To evaluate the clinical application value of platelet analyzer PL-11.
Methods: This study included 69 patients with non-ST-elevation acute coronary
syndrome (NSTE-ACS) requiring selective percutaneous coronary intervention
(PCI). Blood samples obtained at 6–12 hours after a 600mg loading dose of clo-
pidogrel were assayed using continuous platelet count with PL-11 [adenosine
diphosphate (ADP) as the agonist] and vasodilator stimulated phosphoprotein
(VASP) assay. The results were described as maximal aggregation ratio (MAR) and
platelet reactivity index (PRI) respectively. A PRI  50% was deﬁned as high
platelet reactivity (HPR). The platelet function of patients with HPR were detected
respectively by the above two methods in 3 days and 7 days after antiplatelet drug
maintenance treatment.
Results: There was a strong correlation between PL-MAR and VASP-PRI (Pearson
r¼0.77, P<0.01). The receiver-operator characteristic curve (ROC) analysis showed
that the best cutoff point of MAR to distinguish between VASP-deﬁned normal and
HPR was 38%. The area under the curve (AUC) was 0.904 (P<0.001, 95%CI: 0.84-
0.97). The sensitivity and speciﬁcity of PL-11 to detect HPR were 93.5%, 76.3%.
There were good consistencies among the PL-11 and VASP assay in classifying pa-
tients to normal or HPR categories (after 600mg clopidogrel: Kappa¼0.68, P<0.01;
after 3 days therapy: Kappa¼0.73, P<0.01; after 7 days therapy: Kappa¼0.70,
P<0.01).
Conclusions: Good correlations and consistencies among PL-11 and VASP assay
suggested the ability of PL-11 to detect the platelet aggregation function. Further
randomized studies are required to conﬁrm the cut-off value of HPR detected by
PL-11.
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Point-of-care sensitive cardiac troponin I in the rapid triage of chest pain patients
in emergency department
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Liao Xiao-Xing, Li Xin
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Objectives: To evaluate the clinical effectiveness of point-of-care sensitive cardiac
troponin I (POC-cTnI) in emergency department setting amongst acute chest pain
patients with suspected NSTEMI.
Methods: 220 participants who suspected with NSTEMI were recruited consecutively
between July 2012 and January 2013, the participants were randomized into two
groups (POCT vs CLT) after having their baseline characteristics collected. In the
POCT arm, patients had their POCT levels measured both at time zero of emergency
attendance and 3 hours after emergency admission. In the CLT arm, patients were
managed with current hospital guidelines, including a CLT-cTnT level both upon
attendance and 6 hours after, while the other diagnostic and/or therapeutic manage-
ments were at the discretion of the clinician. All participants were followed for 90
days. The primary outcome measures: 1 the triage decision-making time and the
duration of initial emergency stay; 2. the rate of successful home discharges within
6 hours after Emergency visit and no MACE up to 90 days. The secondary outcome
measures included the duration of cardiology department/CCU stay, the subsequent
outpatient’s visits, emergency revisits, hospital readmissions and major adverse car-
diac events over the 90 days follow-up.
Results: 216 participants were successfully followed up. 1 and 3 patients lost to
follow-up in POCT arm and CTL arm respectively. The POCT arm was associated
with less time on mean time of triage decision-making (246min vs 178.5min;
P<0.001), reduced mean length of initial emergency stay (7.2h vs 10.1h; P<0.001),
and increased rate of successful discharge at initial attendances (37/109 (33.9%) vs
9/107 (8.4%) ; OR 7.153,95%CI 3.051 to 16.774; P<0.001). Between the two arms,
there was no difference in the mean duration of cardiovascular wards stay (including
cardiology department and CCU) (3.1 vs 3.0; P¼0.972). Nevertheless, the POCT arm
has more mean inpatients days in CCU (2.0 vs 0.8,P ¼0.045) and less mean inpatients
days in cardiology department (1.1 vs 2.3,P¼0.038). At 90 days follow-up, the POCT
arms had a lower rate of emergency department re-attendance (11 (10.6%) vs 22
(21.2%) ; P¼0.037) and also a lower rate of hospitalization for cardio-vascular reasons
(12 (11.0%) vs 24 (22.4%) ; OR 0.42,95%CI 0.200 to 0.920; P¼0.030). Meanwhile,
there is no difference in any adverse event of MACE, including death, non-fatal
myocardial infarction, or hospitalization for cardio-vascular reasons without
myocardial infarction (44 (40.4%) vs 47 (43.9%); OR 0.850, 95%CI 0.485 to 1.490;
P¼0.571).JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CConclusions: POC-cTnI assessment could rapidly triage chest pain patients with
suspected AMI. This assay could especially increase the rate of successful discharge
amongst low-risk patients, while not increasing the occurrence of MACE at 90 days
follow-up.
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Combining fragmented QRS and TIMI score for predicting in-hospital short-
term prognosis after acute myocardial infraction
Sheng Qinhui
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Objectives: To investigate the joint effect of fQRS and TIMI risk score on predicting
short-term prognostic in patients with acute myocardial infarction.
Methods: 300 patients with AMI were conducted with retrospective analysis on pa-
tients’ clinical data in order to assess the relationship between fQRS with the risk score
and prognosis.
Results: (1) The fQRS with TIMI risk score would provide more sensitive and spe-
ciﬁc prediction of prognosis for AMI patients. In patients of positive fQRS, whose
TIMI score  4 but without PCI intervention had elevated LVSD and mortality rates
(p¼ 0.046, 0.009). In the group with TIMI score < 4 and without PCI intervention
treatment, these patients showed 3x and 3.5x the rates of malignant cardiac arrhythmia
and mortality, respectively, when compared to the intervention group (p-values as
0.012 and 0.004).
Conclusions: (1) fQRS with TIMI risk score could increase the sensitivity and the
speciﬁcity for prognosis evaluating for AMI patients. Patients of AMI with positive
fQRS, who underwent early revascularization, could lower the incidence rate of
cardiovascular event. And, the presence of fQRS could be used as an indication of
early intervention treatment for patients with TIMI score < 4.
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A preliminary study of serum CA125 levels, mechanism and clinical signiﬁcance
in patients with acute myocardial infarction
Deng Jiahua, Pan Jiahua, Wang Qixian
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Objectives: 1 To explore the changes of serum CA125, mechanism and clinical
signiﬁcance in patients after AMI, and according to its ﬂuctuation we shall assess the
condition and guide the treatment of HF after AMI; 2. It’s better to comprehend the
pathophysiology of the HF after AMI from ﬂuid overload of the systemic and pul-
monary circulation.
Methods: 88 cases with AMI was study group, and 30 PSVT cases with normal
cardiac function was control.AMI patients did physical examination to distinguish
killip classiﬁcations immediately at admission respectively, Venous blood samples
were taken at admission and after 48 hours from the ﬁrst taken to check the serum
CA125.All patients measured the hs-CRP, BNP and echocardiography at least once.
There were 10 patients in critical condition and lined the deep venous catheter to
monitor CVP to guide therapy in AMI group. We deﬁne DCA125 as which CA1252
divided by CA1251at early AMI (myocardial infarction in 24 hours to complete the
ﬁrst CA125 check).
Results: 1.CA125, DCA125 and BNP are closely related to killip classiﬁcations; 2.
CA125 after 48 hours with EF less than 50% and killip classiﬁcation more than II, III,
ivof the AUC respectively was 0.898, 0.877, 0.898 , 0.797, its moderate diagnosis cut-
off point were more than 8.92, 7.99, 8.92, 15.0 U / mL; 3. DCA125 with EF less than
50% and killip classiﬁcation more than II, III, ivof the AUC was 0.818, 0.930, 0.958,
0.900, its better diagnostic cut-off point is more than 2.75, 3.06 , 7.71, 8.85 in turn; 5.
Accuracy that DCA125 identify killip classiﬁcations is better than the other; 6. CA125
is relation to hs-CRP, BNP, EF (R¼0.435, 0.660, -0.677, P<0.001). DCA125 is
relation to hs-CRP, BNP, EF (R¼0.524, 0.559, -0.623, P<0.001).
Conclusions: 1 CA125 and DCA125 depend on cardiac function and the time of post-
AMI; 2. when CA125 more than 8.92, 7.99, 8.92, 15.0 U / mL, it suggest that EF are
less than 50% and killip classiﬁcations are more thanII, III, iv in turn; 3. when
DCA125 more than 2.75 , 3.06, 7.71, 8.85, it suggest that patients EF less than 50%
and killip classiﬁcations are more thanII, III, iv in turn; 4 The elevated serum CA125
values may be related to ﬂuid overload and inﬂammatory.6. Necrosis myocardial cells
don’t elevate serum CA125; 7.The increased CVP and PCWP may be related to the
serum CA125; 8. Accuracy that DCA125 values identify different killip classiﬁcations
is better than the other.
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Effect of Rosuvastatin on Atherosclerosis Plaque Biomechanics Patients with
Metabolic Syndrome Using Multiple Tracking Techniques
Wang Zhiyun, Wang Zhiyun
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Objectives: To assess the changes of the velocity, strain and strain rate on carotid
atherosclerosis plaque biomechanics before and after treatment of rosuvastatin for
6 months.
Methods: 96 patients with metabolic syndrome according to the results of according
to the diagnostic standard of IDF underwent the high frequency ultrasound scanning
two carotid arteries in this study. Detected carotid artery intima media thickness.ardiovascular Disease Clinical Research C131
